In one of the last Proactive videos, NP made it clear that they were also discussing a possible licensing agreement for cancer. He said possible future licensing agreements.
In the end of Next super stock said it would say at the next shareholders meeting how far they had come with the NASH licensing agreement if the results were positive. And he said NASH was ahead of mTNBC as the first possible agreement where they could receive significant upfront payment. Given that science proves the value of Leronlimab every day, NP is obviously in multi-party negotiations and will choose what is best, it doesn't matter now a couple of days before or after. The share price is another story and those who have the ability to buy now are the lucky ones.